Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine

Friday, February 28, 2020 1 min read

Key Takeaway: Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine

Full Press Release Details

Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine.